Skip Navigation
Skip to contents

SSBH 2021

Today : 2025.01.22
D +1329
Day 3
June 5(Sat)
09:00-10:10
Oral Presentation 4 [Clinical]
CHANNEL 1
Chairperson(s)
Dong Won Byun (Soonchunhyang University, Korea), Hyun Sik Gong (Seoul National University, Korea)
09:00-09:10 Prospective comparison of 1-year change of handgrip strength in hip fracture patients and hip disease patients Chul-Ho Kim (Chung-Ang University, Korea)
09:10-09:20 Lack of association between water intake and hand grip strength in community-dwelling older adults Hyeonmok Kim (Seoul medical center, Korea)
09:20-09:30 Which skeletal muscle mass index is the most useful in diagnosing sarcopenia and predicting mortality in hip fracture patients? Hong Seok Kim (Seoul National University Hospital, Korea)
09:30-09:40 Risk factors of subsequent hip fracture and fatality rate after hip fracture in Korea Jiwon Jeong (Gyeongsang National University Hospital, Korea)
09:40-09:50 Effect of preoperative vitamin D deficiency on functional outcomes after high tibial osteotomy: a retrospective case control study Seong-Eun Byun (CHA University, Korea)
09:50-10:00 Comparison of femoral neck shortening and outcomes between in situ fixation and fixation after reduction for severe valgus-impacted femoral neck fractures Junwoo Byun (Yonsei University, Korea)
10:00-10:10 What’s difference of the femur geometry between patients with atypical femur fracture and general population? Ji Wan Kim (University of Ulsan, Korea)
Day 3
June 5(Sat)
10:20-11:35
Symposium 5 [Clinical]
Recent development of biomarkers CHANNEL 1
Chairperson(s)
Sang Wan Kim (Seoul National University, Korea), Yumie Rhee (Yonsei University, Korea)
10:20-10:45 Biomarkers of cellular senescence Nathan K. LeBrasseur (Mayo Clinic, USA)
10:45-11:10 D3Cr muscle mass: A new approach Peggy Cawthon (UCSF, USA)
11:10-11:35 Sphingosine-1-phosphate (S1P) as a biomarker of fracture risk Seung Hun Lee (University of Ulsan, Korea)
Day 3
June 5(Sat)
11:50-12:40
Plenary Lecture 3
CHANNEL 1
Chairperson(s)
Zang Hee Lee (Seoul National University, Korea)
11:50-12:40 Fat talks to bone Ki-Choul Kim (Dankook University, Korea), Sung Bae Park (Seoul National University, Korea)
Day 3
June 5(Sat)
12:45-13:00
Sponsored Lecture 2
CHANNEL 1
Chairperson(s)
Yong-Ki Min (Sungkyunkwan Univeristy, Korea)
12:45-13:00 Why not zoledronic acid? Evidence, indications, compliance Young-Kyun Lee (Seoul National University)
Day 3
June 5(Sat)
13:30-14:30
Oral Presentation 6 [Clinical]
CHANNEL 1
Chairperson(s)
Kihyun Baek (The Catholic University of Korea, Korea), Jung-Ho Shin (Korea University, Korea)
13:30-13:40 Transcriptomic profiling of parathyroid tumors reveals distinctive molecular characteristics of carcinoma and adenoma Namki Hong (Yonsei University, Korea)
13:40-13:50 Circulating miR-122-5p and miR-375 is a potential biomarker for recovery of bone mass after parathyroidectomy in primary hyperparathyroidism Seunghyun Lee (Yonsei University, Korea)
13:50-14:00 Skeletal effects of combined bisphosphonates treatment and parathyroidectomy in osteoporotic patients with primary hyperparathyroidism Hun Jee Choe (Seoul National University Hospital, Korea)
14:00-14:10 Incidence and risk of venous thromboembolism in bisphosphonates and selective estrogen receptor modulators treatment in Korea So Young Park (Kyung Hee University Hospital, Korea)
14:10-14:20 Effect of vitamin D supplementation on fracture prevention according to dose and interval: a meta-analysis Sung Hye Kong (Seoul National University Bundang Hospital, Korea)
14:20-14:30 All-cause and cause-specific mortality risks associated with calcium supplementation with or without vitamin D: a nationwide cohort study Kyoung Jin Kim (Korea University, Korea)
Day 3
June 5(Sat)
14:40-15:30
Plenary Lecture 4
CHANNEL 1
Chairperson(s)
Kyu Hyun Yang (Yonsei University, Korea)
14:40-15:30 Combating the high risk of atypical femur fracture risk in Asian vs. Caucasian women: Developing a personalized medicine approach to osteoporosis treatment Dennis Black (UCSF, USA)
Day 3
June 5(Sat)
15:45-17:00
Symposium 7 [Clinical]
Anti-osteoporosis drugs in Korea CHANNEL 1
Chairperson(s)
Dong Jin Chung (Chonnam National Univeristy, Korea), Gun-Il Im (Dongguk University, Korea )
15:45-16:10 The summary & issue of health insurance for treatment of osteoporosis in Korea Hochan Cho (Keimyung University, Korea)
16:10-16:35 Clinical and research perspectives from clinical trials of an anti-sclerostin treatment Jung Min Koh (University of Ulsan, Korea)
16:35-17:00 Osteoporosis in chronic kidney disease Se Hwa Kim (Catholic Kwandong University, Korea)
Sponsors By

KB Hana Bank 352-910018-00804 (Account Holder : Korean Society for Bone and Mineral Research)

#1001, Hyundai Kirim Bldg, 42. Seocho-daero 78-gil, Seocho-gu, Seoul, 06626, Korea
  • Tel : +82-2-3473-2230
  • E-mail : ksbmr@ksbmr.org
  • 대표자 : 정호연 HOYEON CHUNG
  • 사업자등록증번호 : 106-82-62498

Copyright © by Korean Society for Bone and Mineral Research. All right reserved.

Go to Top